Guidance for the X-TOLE2 Phase 3 epilepsy study shifted from the second half of 2025 to "early next year," reflecting a slight timeline delay. Management's strategic focus remains on advancing ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

The healthcare and medical industries are increasingly integrating artificial intelligence into their operations, ...

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

While Quantum computing has been reported to be five years away for many years now, companies are preparing for it by setting ...